We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Microplate Reader for Spectrophotometer

By Biotechdaily staff writers
Posted on 14 Mar 2005
The first microplate reader accessory for the Cary 50 ultraviolet-visible (U-Vis) spectrophotometer is designed to dramatically reduce the cost per analysis and the volume of sample required.

This new Cary 50 microplate reader accessory, from Varian, Inc. More...
(Palo Alto, CA, USA), can accurately perform wavelength scans from 190-1100 nm in up to 384 samples in microliter volumes, in contrast to many dedicated plate readers that have limited scanning capability. In addition to performing low volume, high throughput, nondestructive analyses, another feature of the Cary 50 accessory includes excellent temperature control, allowing measurements to be taken at precise physiologic temperatures or easily adapted for method-development optimization.

Scientists will use the Cary 50 reader accessory for a variety of applications, including enzyme-linked immunosorbent assays (ELISAs), hospital laboratory work, and academic and pharmaceutical R&D. Scientists can also use the accessory for DNA, RNA, and protein quantification and the measurement of enzyme reaction rates to further research in diseases such as cancer.

"We are in the enviable position of being able to offer a complete UV-Vis package consisting of numerous accessories, including the new scanning microplate reader, that can provide a comprehensive platform to suit our customers' needs,” commented Martin O'Donoghue, vice president of Scientific Instruments, Varian, Inc.




Related Links:
Varian, Inc.

Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
Hematology Consumables
Bioblood Devices
Repetitive Pipette
VWR® Stepper Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: Associate Professor Arutha Kulasinghe and non-small cell lung cancer cell (Photo courtesy of The University of Queensland)

Blood-Based Proteomic Test May Predict Treatment Response in Non-Small Cell Lung Cancer

Lung cancer remains the leading cause of cancer death, with non-small cell lung cancer (NSCLC) accounting for most cases. Treatment decisions are often made without a clear indication of how a patient... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.